Marpai appoints Dallas Scrip as president following John Powers resignation

Published 29/08/2025, 13:20
Marpai appoints Dallas Scrip as president following John Powers resignation

Marpai, Inc. (OTCQX:MRAI), a healthcare technology company with a market capitalization of approximately $25 million, announced Friday that John Powers has resigned as president, effective immediately, citing personal health reasons. According to a statement in a press release, the company said Powers’ departure was not related to any disagreement regarding operations, policies, or practices. Powers will remain with Marpai in a part-time advisory capacity as a senior consultant to the sales and leadership teams. InvestingPro data shows the company’s stock has demonstrated remarkable performance, delivering a 220% return over the past year.

Following the resignation, Marpai’s board of directors appointed Dallas Scrip, age 43, as president, effective immediately. Scrip was previously named chief operating officer of the company on June 2, 2025.

Scrip’s background includes serving as president, TPA services and chief delivery officer at Centivo from July 2023 to May 2025. Before that, he was president and general manager of ValueHealth Benefit Administrators from May 2019 through July 2023. Earlier in 2019, Scrip worked as a benefits consultant for Gallagher Benefit Services and previously held the role of senior vice president of business development at Benefit Management, LLC.

Marpai stated there are no arrangements or understandings between Scrip and any other person related to his appointment as president except for his existing compensation agreement. The company also noted there are no transactions involving Scrip that require disclosure under Item 404(a) of Regulation S-K.

This information is based on a statement in a press release and a filing with the Securities and Exchange Commission. Marpai’s Class A common stock trades on the OTCQX Market under the symbol MRAI.

In other recent news, Marpai Inc. announced its financial results for the second quarter of 2025, reporting a net revenue of $4.7 million. This marks a 35% decrease compared to the same quarter in the previous year. Despite the revenue decline, Marpai Inc. made notable progress in reducing its operating and net losses. These developments are part of the company’s ongoing efforts to improve its financial health. The earnings release did not include any updates on mergers or acquisitions. Additionally, there were no recent analyst upgrades or downgrades reported for Marpai Inc. Investors continue to monitor the company’s performance as it navigates these financial challenges.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.